File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Utility of targeted next generation sequencing for inborn errors of immunity at a tertiary care centre in North India

TitleUtility of targeted next generation sequencing for inborn errors of immunity at a tertiary care centre in North India
Authors
Issue Date21-Jun-2022
PublisherNature Research
Citation
Scientific Reports, 2022, v. 12, n. 1 How to Cite?
Abstract

Inborn errors of immunity (IEI) are a heterogeneous group of monogenic disorders that include primary immunodeficiency’s and other disorders affecting different aspects of the immune system. Next-Generation Sequencing (NGS) is an essential tool to diagnose IEI. We report our 3-year experience in setting up facilities for NGS for diagnosis of IEI in Chandigarh, North India. We used a targeted, customized gene panel of 44 genes known to result in IEI. Variant analysis was done using Ion Reporter software. The in-house NGS has enabled us to offer genetic diagnoses to patients with IEI at minimal costs. Of 121 patients who were included pathogenic variants were identified in 77 patients. These included patients with Chronic Granulomatous Disease, Severe Combined Immune Deficiency, leukocyte adhesion defect, X-linked agammaglobulinemia, Ataxia Telangiectasia, Hyper-IgE syndrome, Wiskott Aldrich syndrome, Mendelian susceptibility to mycobacterial diseases, Hyper-IgM syndrome, autoimmune lymphoproliferative syndrome, and GATA-2 deficiency. This manuscript discusses the challenges encountered while setting up and running targeted NGS for IEI in our unit. Genetic diagnosis has helped our patients with IEI in genetic counselling, prenatal diagnosis, and accessing appropriate therapeutic options.


Persistent Identifierhttp://hdl.handle.net/10722/331412
ISSN
2023 Impact Factor: 3.8
2023 SCImago Journal Rankings: 0.900
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRawat, Amit-
dc.contributor.authorSharma, Madhubala-
dc.contributor.authorVignesh, Pandiarajan-
dc.contributor.authorJindal, Ankur Kumar-
dc.contributor.authorSuri, Deepti-
dc.contributor.authorDas, Jhumki-
dc.contributor.authorJoshi, Vibhu-
dc.contributor.authorTyagi, Rahul-
dc.contributor.authorSharma, Jyoti-
dc.contributor.authorKaur, Gurjit-
dc.contributor.authorLau, Yu-Lung-
dc.contributor.authorImai, Kohsuke-
dc.contributor.authorNonoyama, Shigeaki-
dc.contributor.authorLenardo, Michael-
dc.contributor.authorSingh, Surjit-
dc.date.accessioned2023-09-21T06:55:28Z-
dc.date.available2023-09-21T06:55:28Z-
dc.date.issued2022-06-21-
dc.identifier.citationScientific Reports, 2022, v. 12, n. 1-
dc.identifier.issn2045-2322-
dc.identifier.urihttp://hdl.handle.net/10722/331412-
dc.description.abstract<p>Inborn errors of immunity (IEI) are a heterogeneous group of monogenic disorders that include primary immunodeficiency’s and other disorders affecting different aspects of the immune system. Next-Generation Sequencing (NGS) is an essential tool to diagnose IEI. We report our 3-year experience in setting up facilities for NGS for diagnosis of IEI in Chandigarh, North India. We used a targeted, customized gene panel of 44 genes known to result in IEI. Variant analysis was done using Ion Reporter software. The in-house NGS has enabled us to offer genetic diagnoses to patients with IEI at minimal costs. Of 121 patients who were included pathogenic variants were identified in 77 patients. These included patients with Chronic Granulomatous Disease, Severe Combined Immune Deficiency, leukocyte adhesion defect, X-linked agammaglobulinemia, Ataxia Telangiectasia, Hyper-IgE syndrome, Wiskott Aldrich syndrome, Mendelian susceptibility to mycobacterial diseases, Hyper-IgM syndrome, autoimmune lymphoproliferative syndrome, and GATA-2 deficiency. This manuscript discusses the challenges encountered while setting up and running targeted NGS for IEI in our unit. Genetic diagnosis has helped our patients with IEI in genetic counselling, prenatal diagnosis, and accessing appropriate therapeutic options.</p>-
dc.languageeng-
dc.publisherNature Research-
dc.relation.ispartofScientific Reports-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleUtility of targeted next generation sequencing for inborn errors of immunity at a tertiary care centre in North India-
dc.typeArticle-
dc.identifier.doi10.1038/s41598-022-14522-1-
dc.identifier.scopuseid_2-s2.0-85132313440-
dc.identifier.volume12-
dc.identifier.issue1-
dc.identifier.eissn2045-2322-
dc.identifier.isiWOS:000816855900003-
dc.identifier.issnl2045-2322-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats